Survival Benefit of Neoadjuvant Chemotherapy With S-1 Plus Docetaxel for Locally Advanced Gastric Cancer: A Propensity Score-Matched Analysis
Annals of Surgical Oncology - United States
doi 10.1245/s10434-019-07299-7
Full Text
Open PDFAbstract
Available in full text
Date
April 11, 2019
Authors
Publisher
Springer Science and Business Media LLC